Abstract
Summary
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The global Neurological Disease Model Chip market is projected to grow from US$ 54.8 million in 2024 to US$ 87.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period.
The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
Report Includes
This report presents an overview of global market for Neurological Disease Model Chip, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurological Disease Model Chip, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Neurological Disease Model Chip, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurological Disease Model Chip sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Neurological Disease Model Chip market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Neurological Disease Model Chip sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Emulate, CN Bio, TissUse, AxoSim Technologies, Nortis, Mimetas, SynVivo, Axion Biosystems, Tara Biosystems, InSphero, etc.
Market Segmentation
By Company
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Segment by Type
Neuron Chip
Brain Chip
Brain Organ Chip
Segment by Application
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neurological Disease Model Chip in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Neurological Disease Model Chip manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurological Disease Model Chip sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Neurological Disease Model Chip market is projected to grow from US$ 54.8 million in 2024 to US$ 87.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period.
The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
Report Includes
This report presents an overview of global market for Neurological Disease Model Chip, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurological Disease Model Chip, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Neurological Disease Model Chip, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurological Disease Model Chip sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Neurological Disease Model Chip market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Neurological Disease Model Chip sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Emulate, CN Bio, TissUse, AxoSim Technologies, Nortis, Mimetas, SynVivo, Axion Biosystems, Tara Biosystems, InSphero, etc.
Market Segmentation
By Company
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics
Segment by Type
Neuron Chip
Brain Chip
Brain Organ Chip
Segment by Application
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neurological Disease Model Chip in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Neurological Disease Model Chip manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurological Disease Model Chip sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Study Coverage
1.1 Neurological Disease Model Chip Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Disease Model Chip Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Neuron Chip
1.2.3 Brain Chip
1.2.4 Brain Organ Chip
1.3 Market by Application
1.3.1 Global Neurological Disease Model Chip Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical R&D
1.3.3 Neuroscience Research
1.3.4 Clinical Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neurological Disease Model Chip Revenue Estimates and Forecasts 2019-2030
2.2 Global Neurological Disease Model Chip Revenue by Region
2.2.1 Global Neurological Disease Model Chip Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Neurological Disease Model Chip Revenue by Region (2019-2024)
2.2.3 Global Neurological Disease Model Chip Revenue by Region (2025-2030)
2.2.4 Global Neurological Disease Model Chip Revenue Market Share by Region (2019-2030)
2.3 Global Neurological Disease Model Chip Sales Estimates and Forecasts 2019-2030
2.4 Global Neurological Disease Model Chip Sales by Region
2.4.1 Global Neurological Disease Model Chip Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Neurological Disease Model Chip Sales by Region (2019-2024)
2.4.3 Global Neurological Disease Model Chip Sales by Region (2025-2030)
2.4.4 Global Neurological Disease Model Chip Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Neurological Disease Model Chip Sales by Manufacturers
3.1.1 Global Neurological Disease Model Chip Sales by Manufacturers (2019-2024)
3.1.2 Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurological Disease Model Chip in 2023
3.2 Global Neurological Disease Model Chip Revenue by Manufacturers
3.2.1 Global Neurological Disease Model Chip Revenue by Manufacturers (2019-2024)
3.2.2 Global Neurological Disease Model Chip Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Neurological Disease Model Chip Revenue in 2023
3.3 Global Key Players of Neurological Disease Model Chip, Industry Ranking, 2021 VS 2022
3.4 Global Neurological Disease Model Chip Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Neurological Disease Model Chip, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Neurological Disease Model Chip, Product Offered and Application
3.8 Global Key Manufacturers of Neurological Disease Model Chip, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurological Disease Model Chip Sales by Type
4.1.1 Global Neurological Disease Model Chip Historical Sales by Type (2019-2024)
4.1.2 Global Neurological Disease Model Chip Forecasted Sales by Type (2025-2030)
4.1.3 Global Neurological Disease Model Chip Sales Market Share by Type (2019-2030)
4.2 Global Neurological Disease Model Chip Revenue by Type
4.2.1 Global Neurological Disease Model Chip Historical Revenue by Type (2019-2024)
4.2.2 Global Neurological Disease Model Chip Forecasted Revenue by Type (2025-2030)
4.2.3 Global Neurological Disease Model Chip Revenue Market Share by Type (2019-2030)
4.3 Global Neurological Disease Model Chip Price by Type
4.3.1 Global Neurological Disease Model Chip Price by Type (2019-2024)
4.3.2 Global Neurological Disease Model Chip Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Neurological Disease Model Chip Sales by Application
5.1.1 Global Neurological Disease Model Chip Historical Sales by Application (2019-2024)
5.1.2 Global Neurological Disease Model Chip Forecasted Sales by Application (2025-2030)
5.1.3 Global Neurological Disease Model Chip Sales Market Share by Application (2019-2030)
5.2 Global Neurological Disease Model Chip Revenue by Application
5.2.1 Global Neurological Disease Model Chip Historical Revenue by Application (2019-2024)
5.2.2 Global Neurological Disease Model Chip Forecasted Revenue by Application (2025-2030)
5.2.3 Global Neurological Disease Model Chip Revenue Market Share by Application (2019-2030)
5.3 Global Neurological Disease Model Chip Price by Application
5.3.1 Global Neurological Disease Model Chip Price by Application (2019-2024)
5.3.2 Global Neurological Disease Model Chip Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Neurological Disease Model Chip Market Size by Type
6.1.1 US & Canada Neurological Disease Model Chip Sales by Type (2019-2030)
6.1.2 US & Canada Neurological Disease Model Chip Revenue by Type (2019-2030)
6.2 US & Canada Neurological Disease Model Chip Market Size by Application
6.2.1 US & Canada Neurological Disease Model Chip Sales by Application (2019-2030)
6.2.2 US & Canada Neurological Disease Model Chip Revenue by Application (2019-2030)
6.3 US & Canada Neurological Disease Model Chip Market Size by Country
6.3.1 US & Canada Neurological Disease Model Chip Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Neurological Disease Model Chip Revenue by Country (2019-2030)
6.3.3 US & Canada Neurological Disease Model Chip Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Neurological Disease Model Chip Market Size by Type
7.1.1 Europe Neurological Disease Model Chip Sales by Type (2019-2030)
7.1.2 Europe Neurological Disease Model Chip Revenue by Type (2019-2030)
7.2 Europe Neurological Disease Model Chip Market Size by Application
7.2.1 Europe Neurological Disease Model Chip Sales by Application (2019-2030)
7.2.2 Europe Neurological Disease Model Chip Revenue by Application (2019-2030)
7.3 Europe Neurological Disease Model Chip Market Size by Country
7.3.1 Europe Neurological Disease Model Chip Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Neurological Disease Model Chip Revenue by Country (2019-2030)
7.3.3 Europe Neurological Disease Model Chip Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Neurological Disease Model Chip Market Size by Type
8.1.1 China Neurological Disease Model Chip Sales by Type (2019-2030)
8.1.2 China Neurological Disease Model Chip Revenue by Type (2019-2030)
8.2 China Neurological Disease Model Chip Market Size by Application
8.2.1 China Neurological Disease Model Chip Sales by Application (2019-2030)
8.2.2 China Neurological Disease Model Chip Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Neurological Disease Model Chip Market Size by Type
9.1.1 Asia Neurological Disease Model Chip Sales by Type (2019-2030)
9.1.2 Asia Neurological Disease Model Chip Revenue by Type (2019-2030)
9.2 Asia Neurological Disease Model Chip Market Size by Application
9.2.1 Asia Neurological Disease Model Chip Sales by Application (2019-2030)
9.2.2 Asia Neurological Disease Model Chip Revenue by Application (2019-2030)
9.3 Asia Neurological Disease Model Chip Market Size by Region
9.3.1 Asia Neurological Disease Model Chip Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Neurological Disease Model Chip Revenue by Region (2019-2030)
9.3.3 Asia Neurological Disease Model Chip Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Neurological Disease Model Chip Market Size by Type
10.1.1 Middle East, Africa and Latin America Neurological Disease Model Chip Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Neurological Disease Model Chip Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Neurological Disease Model Chip Market Size by Application
10.2.1 Middle East, Africa and Latin America Neurological Disease Model Chip Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Neurological Disease Model Chip Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Neurological Disease Model Chip Market Size by Country
10.3.1 Middle East, Africa and Latin America Neurological Disease Model Chip Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Neurological Disease Model Chip Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Neurological Disease Model Chip Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Emulate
11.1.1 Emulate Company Information
11.1.2 Emulate Overview
11.1.3 Emulate Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Emulate Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emulate Recent Developments
11.2 CN Bio
11.2.1 CN Bio Company Information
11.2.2 CN Bio Overview
11.2.3 CN Bio Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CN Bio Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CN Bio Recent Developments
11.3 TissUse
11.3.1 TissUse Company Information
11.3.2 TissUse Overview
11.3.3 TissUse Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 TissUse Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TissUse Recent Developments
11.4 AxoSim Technologies
11.4.1 AxoSim Technologies Company Information
11.4.2 AxoSim Technologies Overview
11.4.3 AxoSim Technologies Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 AxoSim Technologies Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AxoSim Technologies Recent Developments
11.5 Nortis
11.5.1 Nortis Company Information
11.5.2 Nortis Overview
11.5.3 Nortis Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Nortis Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nortis Recent Developments
11.6 Mimetas
11.6.1 Mimetas Company Information
11.6.2 Mimetas Overview
11.6.3 Mimetas Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Mimetas Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mimetas Recent Developments
11.7 SynVivo
11.7.1 SynVivo Company Information
11.7.2 SynVivo Overview
11.7.3 SynVivo Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 SynVivo Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 SynVivo Recent Developments
11.8 Axion Biosystems
11.8.1 Axion Biosystems Company Information
11.8.2 Axion Biosystems Overview
11.8.3 Axion Biosystems Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Axion Biosystems Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Axion Biosystems Recent Developments
11.9 Tara Biosystems
11.9.1 Tara Biosystems Company Information
11.9.2 Tara Biosystems Overview
11.9.3 Tara Biosystems Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Tara Biosystems Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tara Biosystems Recent Developments
11.10 InSphero
11.10.1 InSphero Company Information
11.10.2 InSphero Overview
11.10.3 InSphero Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 InSphero Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 InSphero Recent Developments
11.11 Hesperos
11.11.1 Hesperos Company Information
11.11.2 Hesperos Overview
11.11.3 Hesperos Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hesperos Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hesperos Recent Developments
11.12 Kugelmeiers
11.12.1 Kugelmeiers Company Information
11.12.2 Kugelmeiers Overview
11.12.3 Kugelmeiers Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Kugelmeiers Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kugelmeiers Recent Developments
11.13 Ascendance Biotechnology
11.13.1 Ascendance Biotechnology Company Information
11.13.2 Ascendance Biotechnology Overview
11.13.3 Ascendance Biotechnology Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Ascendance Biotechnology Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ascendance Biotechnology Recent Developments
11.14 BioIVT
11.14.1 BioIVT Company Information
11.14.2 BioIVT Overview
11.14.3 BioIVT Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 BioIVT Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 BioIVT Recent Developments
11.15 BGI Genomics
11.15.1 BGI Genomics Company Information
11.15.2 BGI Genomics Overview
11.15.3 BGI Genomics Neurological Disease Model Chip Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 BGI Genomics Neurological Disease Model Chip Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 BGI Genomics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurological Disease Model Chip Industry Chain Analysis
12.2 Neurological Disease Model Chip Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurological Disease Model Chip Production Mode & Process
12.4 Neurological Disease Model Chip Sales and Marketing
12.4.1 Neurological Disease Model Chip Sales Channels
12.4.2 Neurological Disease Model Chip Distributors
12.5 Neurological Disease Model Chip Customers
13 Neurological Disease Model Chip Market Dynamics
13.1 Neurological Disease Model Chip Industry Trends
13.2 Neurological Disease Model Chip Market Drivers
13.3 Neurological Disease Model Chip Market Challenges
13.4 Neurological Disease Model Chip Market Restraints
14 Key Findings in the Global Neurological Disease Model Chip Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer